Celastrol alleviates metabolic disturbance in high-fat diet-induced obese mice through increasing energy expenditure by ameliorating metabolic inflammation. Academic Article uri icon


  • Celastrol, a natural triterpene, has been shown to treat obesity and its related metabolic disorders. In this study, we first assessed the relationship between the antiobesity effects of celastrol and its antiinflammatory activities. Our results showed that celastrol can reduce weight gain, ameliorate glucose intolerance, insulin resistance, and dyslipidemia without affecting food intake in high-fat diet-induced obese mice. A CLAMS was used to clarify the improvement of metabolic profiles was attribute to increased adipose thermogenesis after celastrol treatment. Further studies found that celastrol decreased the infiltration of macrophage as well as its inflammatory products (IL-1, IL-18, MCP-1, and TNF-) in liver and adipose tissues, which also displayed an obvious inhibition of TLR3/NLRP3 inflammasome molecules. This study demonstrated that celastrol could be a potential drug for treating metabolic disorders, the underlying mechanism is related to ameliorating metabolic inflammation, thus increasing body energy expenditure.

published proceedings

  • Phytother Res

altmetric score

  • 0.25

author list (cited authors)

  • Yang, X., Wu, F., Li, L., Lynch, E. C., Xie, L., Zhao, Y., ... Chen, G.

citation count

  • 13

complete list of authors

  • Yang, Xueping||Wu, Fan||Li, Lingli||Lynch, Ernest C||Xie, Linglin||Zhao, Yan||Fang, Ke||Li, Jingbin||Luo, Jinlong||Xu, Lijun||Zou, Xin||Lu, Fuer||Chen, Guang

publication date

  • January 2021